In a patient taking regular sumatriptan, how should anesthesia be managed regarding continuation of the medication, avoidance of serotonergic agents, and blood pressure monitoring?

Sumatriptan and Anesthesia Management

In patients taking regular sumatriptan, hold the medication on the day of surgery, but continue it preoperatively up until that point. 1

Medication Timing

The Society for Perioperative Assessment and Quality Improvement (SPAQI) 2021 consensus provides clear guidance on triptan management:

• Continue sumatriptan preoperatively through the days leading up to surgery
• Hold on the day of operation 1
• If acute migraine treatment is needed on the day of surgery, use an alternative non-triptan medication

This recommendation applies to all triptans (sumatriptan, rizatriptan, zolmitriptan, eletriptan, frovatriptan, naratriptan, almotriptan) 1.

Rationale for Holding on Surgery Day

The consensus to hold triptans on the day of surgery is based on several theoretical concerns 1:

1. Serotonin syndrome risk: While the risk of serotonin syndrome when combining triptans with SSRIs or SNRIs is low in routine clinical practice (these are often co-prescribed), the perioperative setting introduces additional serotonergic agents that increase risk
2. Drug metabolism interactions: Triptans are metabolized through multiple pathways including monoamine oxidase A, CYP3A4, CYP2D6, and CYP1A2, creating potential interactions with anesthetic agents 1
3. Cardiovascular effects: Sumatriptan causes 10-20% coronary artery vasoconstriction at clinical doses 2

Serotonergic Agent Avoidance

Exercise caution with perioperative medications that have serotonergic activity, particularly:

• Opioids with serotonin reuptake inhibition: fentanyl, meperidine, methadone, tramadol, tapentadol 1
• Antiemetics: ondansetron, granisetron, metoclopramide 1
• Other agents: linezolid, ritonavir 1

The risk of serotonin syndrome increases when multiple serotonergic agents are combined. However, since sumatriptan is held on the day of surgery and has a half-life of approximately 2.5 hours 3, the risk is substantially mitigated if the medication was last taken the evening before surgery.

Blood Pressure Monitoring

Standard hemodynamic monitoring is sufficient; no special blood pressure protocols are required for patients on sumatriptan 1.

Key considerations:

• Sumatriptan's vasoconstrictor effects are short-lived given its 2.5-hour half-life 3
• The FDA label contraindicates sumatriptan in patients with uncontrolled hypertension, but controlled hypertension is not a contraindication 3
• If the patient has taken sumatriptan within 24 hours of surgery, be aware of potential additive vasoconstrictive effects with vasopressors or local anesthetics with epinephrine

Contraindications to Consider

Verify the patient does not have absolute contraindications to sumatriptan that would also impact anesthetic management 3:

• Coronary artery disease or vasospasm
• History of stroke or TIA
• Peripheral vascular disease
• Uncontrolled hypertension
• Severe hepatic impairment

Common Pitfalls

1. Do not discontinue sumatriptan days before surgery - this is unnecessary and may lead to uncontrolled migraines preoperatively
2. Do not assume all migraine medications require the same management - ergotamine requires holding at least 2 days prior to surgery due to prolonged vasoconstriction 1
3. Do not withhold appropriate opioid analgesia out of excessive fear of serotonin syndrome - the risk is theoretical and low when sumatriptan is held on surgery day